Hinton, W., Feher, M., Munro, N., Joy, M., & de Lusignan, S. (2021). Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: Influence of renal function and heart failure diagnosis. BioMed Central.
Chicago-čujuhus (17. p.)Hinton, W., MD Feher, N. Munro, M. Joy, juo S. de Lusignan. Prescribing Sodium-glucose Co-transporter-2 Inhibitors for Type 2 Diabetes in Primary Care: Influence of Renal Function and Heart Failure Diagnosis. BioMed Central, 2021.
MLA-čujuhus (9. p.)Hinton, W., et al. Prescribing Sodium-glucose Co-transporter-2 Inhibitors for Type 2 Diabetes in Primary Care: Influence of Renal Function and Heart Failure Diagnosis. BioMed Central, 2021.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.